Sage is attending BioEurope Spring in Lisbon from March 23-25, 2026! Please click here to meet!

WHERE LIFE SCIENCE INNOVATION MEETS GLOBAL DEAL-MAKING!​

Sage Healthcare is a specialist transaction advisory firm helping biotech, pharma, and health-technology companies license, partner and complete strategic M&A — worldwide.

​

Our principals have led more than 200 multinational transactions across the United States, Europe, Japan, China, Australia, the Middle East and Latin America, covering assets from preclinical to early clinical stage through to global commercial products.

​

Unlike generalist investment banks or consulting firms, Sage operates as a highly specialised transaction platform. We combine deep sector expertise, direct access to corporate decision-makers, and proprietary AI-driven analytics to identify, qualify and close the right transactions for our clients.

​

Sage maintains offices and affiliated teams across North America, Europe, Israel and Asia-Pacific, allowing us to operate continuously across time zones and cultures and to engage decision-makers in their local markets.

​

VALUE PROPOSITION 

Global reach. Deep science. Proven deal execution.

Sage combines the analytical power of AI-driven market intelligence with the hands-on experience of senior transaction professionals who have closed hundreds of international healthcare deals.

We don’t provide advice from the sidelines. We run your process, build your buyer universe, manage negotiations, and close transactions that maximise long-term value.

​

WHO WE SERVE

Tailored transaction strategies for every stakeholder

Biotech & MedTech Companies
Commercialise assets, secure development partners, raise capital, or exit through licensing and M&A.

​

Pharmaceutical & Strategic Buyers
Identify and acquire high-quality innovation globally through disciplined, data-driven deal sourcing.

 

Investors & Owners
Maximise enterprise value through structured sale, recapitalisation, or partnering processes.

​